- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02164383
A Quit Smoking Study Using Smartphones
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53711
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- being age 18 or older;
- being able to read and write English;
- being willing and able to learn how to use a smartphone if they have not used one before;
- smoking 10 or more cigarettes per day for the past 6 months;
- having an expired carbon monoxide rating of 6 ppm or greater;
- not having been diagnosed with or treated for schizophrenia, psychosis or bipolar disorder in the past 10 years;
- being willing to make a quit attempt in 2 weeks;
- agreeing to attend clinic visits, receive coaching calls, and complete brief smartphone assessments;
- planning to remain in the area for at least the next 2 months;
- using the following alternative tobacco products (a pipe, full sized cigars, snuff or chew) no more than two times a week over the past month;
- being willing to stop using electronic cigarettes (e-cigarettes) for the 6 weeks they are in the study;
- not currently taking bupropion, Wellbutrin, or Zyban;
- if currently using nicotine replacement therapy or Varenicline, agreeing to use only study medication for the duration of the study;
- being willing and able to use the nicotine patch;
- never having had a serious skin reaction or other allergic reaction to the nicotine patch;
- not pregnant, trying to conceive, or nursing;
- if a woman of childbearing potential, agreeing to use or having their partner use an acceptable method of birth control during a 2 month period (1 month of nicotine patch and 1 month after). (Acceptable methods of birth control include: abstinence, condoms, diaphragm, birth control pills or injectable contraceptive [e.g., Depo-Provera], an intrauterine device, hysterectomy, tubal ligation, sterilization, vasectomy, or being more than 2 years post-menopausal.)
- Participants need to report playing video games for no more than 60 minutes a day.
- Although participants can play console games, they need to be willing to not play any mobile games for 6 weeks during the study if they are asked to do so.
- Participants need to report being willing to stay in the study even if they are not at first successful in quitting smoking.
- They need to report that they have a way to get to the clinic.
Exclusion Criteria:
- They will be excluded if in the last 4 weeks they have been hospitalized for any of the following: a stroke, heart attack, congestive heart failure, or an abnormal electrocardiogram.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Mobile Games
This arm of the project will address the following question: How effective is the following intervention? Nicotine patch plus behavioral cessation counseling with access to Mobile Games. |
4-week starter kit of nicotine patch
5 brief counseling sessions
|
|
Eksperimentel: No Mobile Games
This arm of the project will address the following question: How effective is the following intervention: Nicotine patch plus behavioral cessation counseling without access to Mobile Games. |
4-week starter kit of nicotine patch
5 brief counseling sessions
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change Between Baseline Mean Cigarettes Smoked Per Day and Mean Cigarettes Smoked Per Day During the First 4 Weeks of the Quit Attempt Calculated as Percentage Change
Tidsramme: Cigarettes per day measured daily for the first 4 weeks of the quit attempt (starting on the target quit day) and at baseline
|
Every day participants will report the number of cigarettes they smoked that day at baseline and for the first 4 weeks of the quit attempt (starting on the target quit day) using timeline followback assessment.
This information will be used to calculate a participant's change in mean cigarettes smoked per day from baseline compared to the mean across the first 4 weeks of the quit attempt calculated as percentage change.
|
Cigarettes per day measured daily for the first 4 weeks of the quit attempt (starting on the target quit day) and at baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Tanya R. Schlam, PhD, University of Wisconsin Center for Tobacco Research and Intervention
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Kemisk inducerede lidelser
- Stof-relaterede lidelser
- Tobaksbrugsforstyrrelse
- Lægemidlers fysiologiske virkninger
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Autonome agenter
- Agenter fra det perifere nervesystem
- Kolinerge midler
- Ganglionstimulerende midler
- Nikotiniske agonister
- Kolinerge agonister
- Nikotin
Andre undersøgelses-id-numre
- 2013-1606
- P50CA143188 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .